PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
38,959,310
Share change
-524,370
Total reported value
$58,833,270
Put/Call ratio
125%
Price per share
$1.51
Number of holders
70
Value change
-$767,790
Number of buys
18
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2024

As of 31 Dec 2024, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,959,310 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Sio Capital Management, LLC, ArrowMark Colorado Holdings LLC, BML Capital Management, LLC, Euclidean Capital LLC, ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, PFM Health Sciences, LP, ACADIAN ASSET MANAGEMENT LLC, and BlackRock, Inc.. This page lists 70 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.